Caption Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Sell
16,316
-33,684
-67% -$2.35M 0.01% 1020
2025
Q4
$3.32M Buy
50,000
+7,800
+18% +$504K 0.02% 647
2025
Q3
$2.84M Buy
42,200
+25,600
+154% +$2.03M 0.02% 702
2025
Q2
$1.45M Buy
16,600
+3,200
+24% +$251K 0.02% 822
2025
Q1
$915K Buy
+13,400
New +$1.09M 0.01% 950
2024
Q3
Sell
-11,900
Closed -$977K 1366
2024
Q2
$1.35M Buy
+11,900
New +$1.5M 0.02% 578
2023
Q4
Sell
-1,936
Closed -$198K 1415
2023
Q3
$181K Sell
1,936
-13,064
-87% -$1.47M ﹤0.01% 1104
2023
Q2
$1.93M Hold
15,000
0.03% 504
2023
Q1
$1.74M Buy
15,000
+14,028
+1,443% +$1.57M 0.03% 483
2022
Q4
$110K Buy
+972
New +$107K ﹤0.01% 1127
2022
Q2
Sell
-43,200
Closed -$3.94M 1533
2022
Q1
$5.53M Buy
43,200
+35,296
+447% +$3.86M 0.07% 385
2021
Q4
$1.06M Buy
+7,904
New +$1.14M 0.01% 1023
2021
Q2
Sell
-82,904
Closed -$7.96M 1367
2021
Q1
$7.45M Buy
82,904
+76,904
+1,282% +$7.22M 0.16% 162
2020
Q4
$554K Buy
6,000
+3,200
+114% +$286K 0.01% 722
2020
Q3
$287K Sell
2,800
-896
-24% -$93.6K 0.01% 860
2020
Q2
$376K Buy
+3,696
New +$331K 0.01% 721
2020
Q1
Sell
-64,328
Closed -$3.52M 903
2019
Q4
$3.52M Buy
+64,328
New +$3.05M 0.12% 241

Other funds holding DXCM

Caption Management's DXCM Position: Q1 2026 in Review

Caption Management reduced its DexCom (DXCM) stake by 67% in Q1 2026, selling an estimated $2.35M and leaving 16,316 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #1020.

Caption Management first reported a position in DXCM in Q4 2019 and has held it in 17 quarters since. The position peaked at $7.45M in Q1 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Caption Management held 16,316 shares of DexCom worth $1.02M as of Q1 2026.
  • Caption Management sold 33,684 DexCom shares in Q1 2026, an estimated $2.35M.
  • DexCom made up 0.01% of Caption Management's portfolio in Q1 2026, its #1020 holding.
  • Caption Management first reported a position in DexCom in Q4 2019 and has held it in 17 quarters since.
  • Caption Management's DexCom position peaked at $7.45M in Q1 2021.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.